Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Spinocerebellar Ataxia Type 10 Repeat Expasion Analysis (Prenatal Diagnosis) Baylor Genetics United States | 1 | 1 |
|
SCA10 (ATXN10) Genetic TestingĀ (Repeat expansion) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 1 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 166 | 120 |
|
Spinocerebellar ataxia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 38 | 37 |
|
Spinocerebellar Ataxia Repeat Panel (SCA 8, 10, 12, 17, 36, & DRPLA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 6 | 6 |
|
Comprehensive Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, DRPLA & FRDA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 12 | 12 |
|
ATXN10 (Spinocerebellar Ataxia Type 10) Repeat Expansion Fulgent Genetics United States | 1 | 1 |
|
Ataxia Repeat Expansion Analysis Fulgent Genetics United States | 19 | 15 |
|
Ataxia Related Disorders , Panel Massive Sequencing (NGS) 35 Genes Reference Laboratory Genetics Spain | 37 | 34 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 11 | 11 |
|
SPINOCEREBELLAR ATAXIA (AUTOSOMAL DOMINANT) (SCAs) Laboratorio de Genetica Clinica SL Spain | 18 | 19 |
|
Ataxia, Complete Dominant Evaluation Athena Diagnostics United States | 31 | 25 |
|
Ataxia, Comprehensive Evaluation Athena Diagnostics United States | 44 | 42 |
|
Ataxia, Common Repeat Expansion Evaluation Athena Diagnostics United States | 8 | 8 |
|
Spinocerebellar ataxia type 10 Bioarray Spain | 1 | 1 |
|
Ataxia and differential diagnoses Panel CeGaT GmbH Germany | 172 | 204 |
|
Fulgent Genetics United States | 1 | 1 |
|
SCA10 (ATXN10) Repeat Expansion Test Athena Diagnostics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 141 | 97 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.